BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1936481)

  • 1. Oral antidiabetic combination therapy with sulphonylureas and metformin.
    Haupt E; Knick B; Koschinsky T; Liebermeister H; Schneider J; Hirche H
    Diabete Metab; 1991 May; 17(1 Pt 2):224-31. PubMed ID: 1936481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of alpha-glucosidase inhibitor (acarbose) combined with sulfonylurea or sulfonylurea and metformin in treatment of non-insulin-dependent diabetes mellitus.
    Vannasaeng S; Ploybutr S; Nitiyanant W; Peerapatdit T; Vichayanrat A
    J Med Assoc Thai; 1995 Nov; 78(11):578-85. PubMed ID: 8576667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of pioglitazone as add-on therapy to metformin or sulphonylurea compared to a fixed-dose combination of metformin and glibenclamide on diabetic dyslipidaemia.
    Comaschi M; Corsi A; Di Pietro C; Bellatreccia A; Mariz S;
    Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):373-9. PubMed ID: 17919894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of metformin versus guar in combination with sulphonylureas in the treatment of non insulin dependent diabetes.
    Wilson JA; Scott MM; Gray RS
    Horm Metab Res; 1989 Jun; 21(6):317-9. PubMed ID: 2777189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled insulin as adjunctive therapy in subjects with type 2 diabetes failing oral agents: a controlled proof-of-concept study.
    Hausmann M; Dellweg S; Osborn C; Heinemann L; Buchwald A; Rosskamp R; Genova P; Heise T
    Diabetes Obes Metab; 2006 Sep; 8(5):574-80. PubMed ID: 16918593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pioglitazone, rosiglitazone, and rosiglitazone + metformin: new drugs. Glitazone + oral antidiabetic combination: inadequately evaluated.
    Prescrire Int; 2005 Aug; 14(78):133-9. PubMed ID: 16106595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of combination therapy of troglitazone and sulphonylureas in patients with Type 2 diabetes who were poorly controlled by sulphonylurea therapy alone.
    Iwamoto Y; Kosaka K; Kuzuya T; Akanuma Y; Shigeta Y; Kaneko T
    Diabet Med; 1996 Apr; 13(4):365-70. PubMed ID: 9162613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined metformin and insulin therapy for patients with type 2 diabetes mellitus.
    Ponssen HH; Elte JW; Lehert P; Schouten JP; Bets D
    Clin Ther; 2000 Jun; 22(6):709-18. PubMed ID: 10929918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of type 2 diabetes mellitus with special reference to metformin therapy.
    Campbell IW
    Diabete Metab; 1991 May; 17(1 Pt 2):191-6. PubMed ID: 1936475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy of acarbose in diabetes mellitus: a critical review of controlled trials.
    Scheen AJ
    Diabetes Metab; 1998 Sep; 24(4):311-20. PubMed ID: 9805641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy, tolerability and safety of nateglinide in combination with metformin. Results from a study under general practice conditions.
    Schatz H; Schoppel K; Lehwalder D; Schandry R
    Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):262-6. PubMed ID: 12951631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.
    Hermansen K; Kipnes M; Luo E; Fanurik D; Khatami H; Stein P;
    Diabetes Obes Metab; 2007 Sep; 9(5):733-45. PubMed ID: 17593236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Oral antidiabetic therapy].
    Schneider S; Pazdzierny G; Klein HH
    Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S264-7. PubMed ID: 17139584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic effects of combined sulphonylurea and metformin therapy in maturity-onset diabetice.
    Nattrass M; Hinks L; Smythe P; Todd PG; Alberti KG
    Horm Metab Res; 1979 May; 11(5):332-7. PubMed ID: 573232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pitfalls and precautions concerning the use of conventional oral antidiabetic drugs].
    Scheen AJ
    Rev Med Liege; 2002 May; 57(5):352-6. PubMed ID: 12143186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of initial oral antidiabetic treatment in patients with type 2 diabetes mellitus.
    Jermendy G; Wittmann I; Nagy L; Kiss Z; Rokszin G; Abonyi-Tóth Z; Katona L; Paragh G; Karádi I; Merkely B
    Med Sci Monit; 2012 Feb; 18(2):CR72-77. PubMed ID: 22293880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of metformin in treatment of diabetes mellitus.
    Vigneri R; Goldfine ID
    Diabetes Care; 1987; 10(1):118-22. PubMed ID: 3552509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Further results of a multi-centre clinical trial with the oral antidiabetic drug glisoxepide (author's transl)].
    Blumenbach L; Kiesselbach N; Lehnert J
    Arzneimittelforschung; 1976; 26(5):931-43. PubMed ID: 786303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of diabetes mellitus with oral drugs].
    Dieterle C
    Med Klin; 1978 Dec; 73(49):1724-9. PubMed ID: 723759
    [No Abstract]   [Full Text] [Related]  

  • 20. Blood lactate and pyruvate levels in diabetic patients treated with biguanides with and without sulphonylureas.
    Waters AK; Morgan DB; Wales JK
    Diabetologia; 1978 Feb; 14(2):95-8. PubMed ID: 631461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.